Sodium 4-aminobenzoate, 95.0%, 500g

3-(Dicyanomethylidene)indan-1-one>98.0%(GC)1g

2,2,2-Trichloro-1-[1-(2-nitro-4-trifluoromethyl-phenyl)-1H-pyrrol-2-yl]-ethanone, 95.0%, 5g

7-Bromothieno[3,2-b]pyridine, 95.0%, 100mg

(R)-4-Phenyloxazolidine-2-thione, 98%, 1g

(R)-3-(((9H-Fluoren-9-yl)methoxy)carbonyl)thiazolidine-4-carboxylic acid, 98.0%, 10g

GC capillary column ROTI®Cap-5, 15 m, 0.32 mm, 0.10 µm, 1 Piece(s)

(1S,2R)-2-(Benzyloxymethyl)-1-hydroxy-3-cyclopentene, 90.0%, 5g

2-Phenyl-1H-benzo[d]imidazole-5-sulfonic acid, 95.0%, 500g

methyl 3-{[3-(1H-imidazol-1-yl)propyl]amino}-2-methylpropanoate, 95.0%, 10g

2-Hydroxy-2-(2-nitrophenyl)acetonitrile, 100mg

5,10,15,20-Tetrakis(2-pyridyl)porphyrin, 97%, 25g

N-(Phenylsulfonyl)-N-((trifluoromethyl)thio)benzenesulfonamide, 250mg